Correction: Manganese superoxide dismutase and breast cancer recurrence: A Danish clinical registry-based case-control study, and a meta-analysis (PLoS ONE (2014) 9, 1, (e87450) DOI: 10.1371/journal.pone.0087450);Manganese superoxide dismutase and breast cancer recurrence: A Danish clinical registry-based case-control study, and a meta-analysis

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Cronin Fenton, Deirdre P ^a   Christensen, Mariann ^a   Lash, Timothy L ^a,b   Ahern, Thomas P ^c   Pedersen, Lars ^a   Garne, Jens Peter ^d,e   Ewertz, Marianne ^d,f   Autrup, Herman ^a   Sørensen, Henrik T ^a   Hamilton Dutoit, Stephen ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF VERMONT   (United States)

^d Danish Breast Cancer Cooperative Group   (Denmark)

^e AALBORG UNIVERSITY HOSPITAL   (Denmark)

^f ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CYCLOPHOSPHAMIDE; MANGANESE SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CASE CONTROL STUDY; CONTROLLED STUDY; DENMARK; FEMALE; GENE FREQUENCY; GENETIC CODE; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; PHENOTYPE;

ALLELES; AMINO ACID SUBSTITUTION; ANTINEOPLASTIC AGENTS, ALKYLATING; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; DENMARK; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MUTATION, MISSENSE; NEOPLASM RECURRENCE, LOCAL; REGISTRIES; RETROSPECTIVE STUDIES; SUPEROXIDE DISMUTASE;

EID: 84897568047     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092620     Document Type: Erratum

References (32)

1. Sutton A, Imbert A, Igoudjil A, Descatoire V, Cazanave S, et al. (2005) The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability. Pharmacogenet Genomics 15: 311-319. (Pubitemid 40676552)
2. Chen PM, Wu YH, Li MC, Cheng YW, Chen CY, et al. (2012) MnSOD promotes tumor invasion via upregulation of FoxM1-MMP2 axis and related with poor survival and relapse in lung adenocarcinomas. Mol Cancer Res.
3. Fu TY, Hou YY, Chu ST, Liu CF, Huang CH, et al. (2011) Manganese superoxide dismutase and glutathione peroxidase as prognostic markers in patients with buccal mucosal squamous cell carcinomas. Head Neck 33: 1606-1615.
4. Funke S, Risch A, Nieters A, Hoffmeister M, Stegmaier C, et al. (2009) Genetic polymorphisms in genes related to oxidative stress (GSTP1, GSTM1, GSTT1, CAT, MnSOD, MPO, eNOS) and survival of rectal cancer patients after radiotherapy. J Cancer Epidemiol 2009: 302047.
5. Johnatty SE, Nagle CM, Spurdle AB, Chen X, Australian Breast Cancer Family Study, et al. (2007) The MnSOD Val9Ala polymorphism, dietary antioxidant intake, risk and survival in ovarian cancer (australia). Gynecol Oncol 107: 388-391. (Pubitemid 350160877)
6. Cai Q, Shu XO, Wen W, Cheng JR, Dai Q, et al. (2004) Genetic polymorphism in the manganese superoxide dismutase gene, antioxidant intake, and breast cancer risk: Results from the shanghai breast cancer study. Breast Cancer Res 6: R647-55.
7. Slanger TE, Chang-Claude J, Wang-Gohrke S (2006) Manganese superoxide dismutase ala-9Val polymorphism, environmental modifiers, and risk of breast cancer in a german population. Cancer Causes Control 17: 1025-1031. (Pubitemid 44290767)
8. Mitrunen K, Sillanpaa P, Kataja V, Eskelinen M, Kosma VM, et al. (2001) Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. Carcinogenesis 22: 827-829. (Pubitemid 32447933)
9. Bica CG, da Silva LL, Toscani NV, Zettler CG, Gottlieb MG, et al. (2010) Polymorphism (ALA16VAL) correlates with regional lymph node status in breast cancer. Cancer Genet Cytogenet 196: 153-158.
10. Glynn SA, Boersma BJ, Howe TM, Edvardsen H, Geisler SB, et al. (2009) A mitochondrial target sequence polymorphism in manganese superoxide dismutase predicts inferior survival in breast cancer patients treated with cyclophosphamide. Clin Cancer Res 15: 4165-4173.
11. Yao S, Barlow WE, Albain KS, Choi JY, Zhao H, et al. (2010) Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer. Breast Cancer Res Treat 124: 433-439.
12. Martin RC, Li Y, Liu Q, Jensen NS, Barker DF, et al. (2009) Manganese superoxide dismutase V16A single-nucleotide polymorphism in the mitochondrial targeting sequence is associated with reduced enzymatic activity in cryopreserved human hepatocytes. DNA Cell Biol 28: 3-7.
13. Ambrosone CB, Ahn J, Singh KK, Rezaishiraz H, Furberg H, et al. (2005) Polymorphisms in genes related to oxidative stress (MPO, MnSOD, CAT) and survival after treatment for breast cancer. Cancer Res 65: 1105-1111. (Pubitemid 40216474)
14. Hubackova M, Vaclavikova R, Ehrlichova M, Mrhalova M, Kodet R, et al. (2012) Association of superoxide dismutases and NAD(P)H quinone oxidoreductases with prognosis of patients with breast carcinomas. Int J Cancer 130: 338-348.
15. Ji M, Tang J, Zhao J, Xu B, Qin J, et al. (2012) Polymorphisms in genes involved in drug detoxification and clinical outcomes of anthracycline-based neoadjuvant chemotherapy in chinese han breast cancer patients. Cancer Biol Ther 13: 264-271.
16. Martin RC, Ahn J, Nowell SA, Hein DW, Doll MA, et al. (2006) Association between manganese superoxide dismutase promoter gene polymorphism and breast cancer survival. Breast Cancer Res 8: R45.
17. Sgambato A, Camerini A, Collecchi P, Graziani C, Bevilacqua G, et al. (2009) Cyclin E correlates with manganese superoxide dismutase expression and predicts survival in early breast cancer patients receiving adjuvant epirubicin-based chemotherapy. Cancer Sci 100: 1026-1033.
18. Bewick MA, Conlon MS, Lafrenie RM (2008) Polymorphisms in manganese superoxide dismutase, myeloperoxidase and glutathione-S-transferase and survival after treatment for metastatic breast cancer. Breast Cancer Res Treat 111: 93-101. (Pubitemid 352009233)
19. Ahn J, Ambrosone CB, Kanetsky PA, Tian C, Lehman TA, et al. (2006) Polymorphisms in genes related to oxidative stress (CAT, MnSOD, MPO, and eNOS) and acute toxicities from radiation therapy following lumpectomy for breast cancer. Clin Cancer Res 12: 7063-7070. (Pubitemid 44974505)
20. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Peto R, Davies C, Godwin J, Gray R, et al. (2012) Comparisons between different polychemotherapy regimens for early breast cancer: Meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet 379: 432-444.
21. Moller S, Jensen MB, Ejlertsen B, Bjerre KD, Larsen M, et al. (2008) The clinical database and the treatment guidelines of the danish breast cancer cooperative group (DBCG); its 30-years experience and future promise. Acta Oncol 47: 506-524. (Pubitemid 351878431)
22. Rothman KJ, Greenland S, Lash TL (2008) Case-control studies. In: Rothman K, Greenland S, Lash TL, editors. Modern Epidemiology, 3rd Edition. Philadelphia: Lippincott, Williams & Wilkins. 111-127.
23. Erichsen R, Lash TL, Hamilton-Dutoit S, Bjerregaard B, Vyberg M, et al. (2010) Existing data sources for clinical epidemiology: The danish national pathology registry and data bank. Clin Epidemiol 2: 51-56.
24. Weir B (1996) Genetic data analysis II: Methods for discrete population genetic data. Sunderland, MA: Sinauer Associates.
25. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560. (Pubitemid 37088507)
26. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. (Pubitemid 17189972)
27. Duval S, Tweedie R (2000) Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56: 455-463. (Pubitemid 30422636)
28. Hansen PS, Andersen E, Andersen KW, Mouridsen HT (1997) Quality control of end results in a danish adjuvant breast cancer multi-center study. Acta Oncol 36: 711-714. (Pubitemid 28078929)
29. Ahern TP, Christensen M, Cronin-Fenton D, Lunetta KL, Rosenberg CL, et al. (2010) Concordance of metabolic enzyme genotypes assayed from paraffin-embedded, formalin-fixed breast tumors and normal lymphatic tissue. Clin Epidemiol 2: 241-246.
30. Rae JM, Regan MM, Thibert JN, Gersch C, Thomas D, et al. (2013) Concordance between CYP2D6 genotypes obtained from tumor-derived and germline DNA. J Natl Cancer Inst 105: 1332-1334.
31. Noviello C, Courjal F, Theillet C (1996) Loss of heterozygosity on the long arm of chromosome 6 in breast cancer: Possibly four regions of deletion. Clin Cancer Res 2: 1601-1606. (Pubitemid 126447456)
32. Sheng ZM, Marchetti A, Buttitta F, Champeme MH, Campani D, et al. (1996) Multiple regions of chromosome 6q affected by loss of heterozygosity in primary human breast carcinomas. Br J Cancer 73: 144-147. (Pubitemid 26028326)